首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Novel Aminoquinoline Derivatives Significantly ReduceParasite Load in Leishmania infantum Infected Mice
【2h】

Novel Aminoquinoline Derivatives Significantly ReduceParasite Load in Leishmania infantum Infected Mice

机译:新型氨基喹啉衍生物显着降低婴儿利什曼原虫感染小鼠的寄生虫负荷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this Letter, a detailed analysis of 30 4-aminoquinoline-based compounds with regard to their potential as antileishmanial drugs has been carried out. Ten compounds demonstrated IC50 < 1 μM against promastigote stages of L. infantum and L. tropica, and five compounds showed IC50 < 1 μM against intramacrophage L. infantum amastigotes. Two compounds showed dose-dependent enhancement of NO and ROS production by bone marrow-derived macrophages and remarkable reduction of parasite load in vivo, with advantage of being short-term and orally active. To the best of our knowledge, this is the first example of 4-amino-7-chloroquinoline derivatives active in Leishmania infantum infected mice.
机译:在这封信中,已对30种基于4-氨基喹啉的化合物作为抗衰老药物的潜力进行了详细分析。十种化合物对婴儿乳杆菌和热带乳杆菌的前鞭毛体阶段表现出IC50 <1μM,而五种化合物对巨噬细胞内婴儿乳杆菌变形杆菌的表现出IC50 <1μM。两种化合物显示出骨髓衍生的巨噬细胞对NO和ROS产生剂量依赖性的增强作用,并且体内寄生虫负荷显着降低,具有短期和口服活性。据我们所知,这是在婴儿利什曼原虫感染小鼠中有活性的4-氨基-7-氯喹啉衍生物的第一个实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号